Capital Guardian Trust Company »

Sage Therapeutics shares owned by Capital Guardian Trust Company

Quarter-by-quarter ownership of Sage Therapeutics (SAGE) shares owned by Capital Guardian Trust Company from 13F filings

Historical chart of Capital Guardian Trust Company investment in Sage Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sage Therapeutics held by Capital Guardian Trust Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sage Therapeutics by Capital Guardian Trust Company

Quarter filed Position value Share count Share price at filing
2019-06-30 $22M 122k 183.09

More positions owned by Capital Guardian Trust Company

Enbridge Common Stock (ENB)
Taiwan Semiconductor Mfg Common Stock (TSM)
Asml Holding Nv Common Stock (ASML)
Microsoft Corp Common Stock (MSFT)
Visa Inc Cl A Common Stock (V)
Hdfc Bank Common Stock (HDB)
Facebook Inc Cl A Common Stock (META)
Broadcom Common Stock (AVGO)
Vale Sa On Common Stock (VALE)
Charter Communications Inc Cl A Common Stock (CHTR)
Aon Plc Cl A Common Stock
Ctrip.com Intl Common Stock
Amazon.com Common Stock (AMZN)
Alibaba Group Holding Common Stock (BABA)
Godaddy Inc Cl A Common Stock (GDDY)

View all positions for Capital Guardian Trust Company

Top funds holding Sage Therapeutics

Vanguard Group
Rtw Investments
BlackRock
FMR
Bellevue Group
State Street Corporation
Millennium Management
Jacobs Levy Equity Management
Geode Capital Management
Palo Alto Investors
Acadian Asset Management
Goldman Sachs Group
Citadel Advisors
D. E. Shaw & Co
Federated Investors

View all funds holding Sage Therapeutics